The last word to new FDA draft guidance for cancer clinical trial eligibility criteria for patients with incurable cancer

被引：0
|
作者：
Lythgoe, Mark P. [1 ]
Prasad, Vinay [2 ]
机构：
[1] Imperial Coll London, Hammersmith Hosp, Dept Surg & Canc, Du Cane Rd, London W12 0HS, England
[2] Univ Calif San Francisco, 550 16th St,2nd Fl, San Francisco, CA 94158 USA
来源：
JOURNAL OF CANCER POLICY | 2022年 / 31卷
关键词：
D O I：
10.1016/j.jcpo.2022.100322
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Cancer cachexia: Comparing diagnostic criteria in patients with incurable cancer
    Maria Wiegert, Emanuelly Varea
    de Oliveira, Livia Costa
    Calixto-Lima, Larissa
    da Mota e Silva Lopes, Marcia Soares
    Ferreira Peres, Wilza Arantes
    NUTRITION, 2020, 79-80
  • [12] Reappraisal of eligibility criteria in cancer clinical trials
    Penel, Nicolas
    Lebellec, Loic
    Vanseymortier, Marie
    CURRENT OPINION IN ONCOLOGY, 2018, 30 (05) : 352 - 357
  • [13] Generalizability of common cancer clinical trial eligibility criteria in the real world.
    Karim, Safiya
    Xu, Yuan
    Quan, May Lynn
    Dort, Joseph C.
    Bouchard-Fortier, Antoine
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [14] Screening cancer patients for clinical trial eligibility: A randomized study
    Wright, J.
    Whelan, T.
    Julian, J.
    Simunovic, M.
    Levine, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [15] Are Clinical Trial Eligibility Criteria an Accurate Reflection of a Real World Population of Advanced Lung Cancer Patients?
    Al-Baimani, Khalid
    Jonker, Hannah
    Zhang, Tinghua
    Goss, Glenwood
    Laurie, Scott A.
    Nicholas, Garth
    Wheatley-Price, Paul
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S368 - S369
  • [16] Impact of broadening trial eligibility criteria on the inclusion of patients with brain metastases in cancer clinical trials.
    Unger, Joseph M.
    Xiao, Hong
    Hershman, Dawn L.
    Vaidya, Riha
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [17] FDA releases tissue-agnostic cancer drug draft guidance
    Asher Mullard
    Nature Reviews Drug Discovery, 2022, 21 : 868 - 868
  • [18] FDA releases tissue-agnostic cancer drug draft guidance
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (12) : 868 - 868
  • [19] Impact of prior malignancies on outcome of colorectal cancer; revisiting clinical trial eligibility criteria
    Muneer J. Al-Husseini
    Anas M. Saad
    Hadeer H. Mohamed
    Mohamad A. Alkhayat
    Mohamad Bassam Sonbol
    Omar Abdel-Rahman
    BMC Cancer, 19
  • [20] Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria
    Sun, Xuqi
    Li, Lingling
    Xu, Li
    Zhou, Zhongguo
    Chen, Jinbin
    Wang, Juncheng
    Zhang, Yaojun
    Hu, Dandan
    Chen, Minshan
    BMC CANCER, 2021, 21 (01)
12345